Literature DB >> 16886665

Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.

John N Flanagan1, Michael V Young, Kelly S Persons, Lilin Wang, Jeffrey S Mathieu, Lyman W Whitlatch, Michael F Holick, Tai C Chen.   

Abstract

BACKGROUND: Prostate cells can produce 1alpha,25-dihydroxyvitamin D3 (1alpha,25(OH)2D3) from 25-hydroxyvitamin D3 (25(OH)D3) to regulate their own growth. Here, the questions of whether prostate cells express vitamin D-25-hydroxylase (25-OHase) and can convert vitamin D3 to 1alpha,25(OH)2D3 were investigated.
MATERIALS AND METHODS: Protein and receptor binding assays were used to determine 25(OH)D3 and 1alpha,25(OH)2D3, respectively. Measurements of proliferation by 3H-thymidine incorporation, and 1alpha,25(OH)2D-responsive gene expression by real-time qPCR and by Western blot were used as functional assays for the presence of 25-OHase activity.
RESULTS: Prostate cells metabolized vitamin D3 to 1alpha,25(OH)2D3. Vitamin D3 up-regulated 25(OH)D-24R-hydroxylase and IGFBP3, two 1alpha,25(OH)2D-responsive genes, in prostate cells. CYP2R1 was the major form of 25-OHase expressed in normal and cancerous prostate cells as determined by qPCR.
CONCLUSION: The autocrine synthesis of 1alpha,25(OH)2D3 from vitamin D3 suggests that maintaining adequate levels of serum vitamin D could be a safe and effective chemo-preventive measure to decrease the risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886665

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.

Authors:  William B Grant
Journal:  Am J Pathol       Date:  2008-11       Impact factor: 4.307

Review 2.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

Review 3.  Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications.

Authors:  Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 4.  Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.

Authors:  J S Adams; M Hewison
Journal:  Arch Biochem Biophys       Date:  2012-03-14       Impact factor: 4.013

5.  Low vitamin d status of patients in methadone maintenance treatment.

Authors:  Theresa W Kim; Daniel P Alford; Michael F Holick; Alan O Malabanan; Jeffrey H Samet
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

6.  Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/- mice.

Authors:  Wei Yu; Mark Cline; Larry G Maxwell; David Berrigan; Gustavo Rodriguez; Anni Warri; Leena Hilakivi-Clarke
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

Review 7.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.

Authors:  Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

8.  Targeted delivery of vitamin D3-loaded nanoparticles to C6 glioma cell line increased resistance to doxorubicin, epirubicin, and docetaxel in vitro.

Authors:  Nargess Maleklou; Abdolamir Allameh; Bahram Kazemi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-08       Impact factor: 2.416

9.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

Review 10.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.